What is LNSR's market cap?

$71.75M, based on the Nov 4 close of $5.84.

What is LNSR's P/E ratio?

4.6× trailing-twelve-month earnings of $15.51M.

Does LENSAR pay a dividend?

No regular cash dividend has been paid in the last year.

How much of LNSR is sold short?

307.0K shares, 3.8% of float, as of Oct 15, 2026.

What sector is LNSR in?

Healthcare, in the Surgical Instruments industry.

NASDAQ · LNSRHealthcareSurgical Instruments

LENSAR, Inc. Common Stock (LNSR)

$5.84+4.85%

Close Nov 4, 2026 · split-adjusted

Nov 4, 2026$5.84▼ 51.97% in range

Nov 4, 2025Low $5.01 · High $12.73Nov 4, 2026

What changed · written from our data

As of Nov 4, 2026

LENSAR closed at $5.84 on Nov 4, up 4.85%, 54.1% below its 52-week closing high. Volume of 78.4K shares was 1.74× its 20-day average (above normal).

Split-adjusted performance: -12.8% over one month, +8.4% over six months, -53.3% over one year.

In the quarter ended Jun 30, 2026, revenue was $16.50M, up 18.4% from a year earlier, with a net margin of 10.7%.

Short interest was 307.0K shares at the Oct 15 settlement, down 4.8% from the prior report (3.8% of float, 8.1 days to cover).

Market cap$71.7M12.3M shares

Revenue · quarter$16.5M+18.4% YoY

Diluted EPS$0.10—

P/E · TTM4.6×P/S 1.2×

Net margin10.7%Gross 59.3%

Dividend yieldNone

52-week range5.01 – 12.73−54.1% from high

Volume78.4K1.74× 20-day avg

Volatility · 60d71.4%Annualised

Short % of float3.8%8.1 days to cover

Net cash$9.8MCash $13.6M

Next earnings—Not scheduled

Split-adjusted performance

1W −1.4%1M −12.8%3M +1.8%6M +8.4%YTD −49.8%1Y −53.3%3Y +171.6%5Y −18.5%

Earnings reactions

History →

No reported quarters with price history yet.

Rank within Surgical Instruments

Percentile among 110 companies (100 = best)

6-month momentum61

Revenue growth74

Net margin81

Value (low P/E)90

Size35

Industry medians: 6-month return −4.0%, revenue growth +8.9%, net margin −8.2%, P/E 30.5×.

Short interest

Details →

Shares short307.0K−4.8% vs prior

Days to cover8.1Settled Oct 15

% of float3.8%

Short vol. 10d30.9%of daily volume

Closest peers by size in Surgical Instruments

Company	Price	Today	6M	Rev. growth	Net margin	P/E	Mkt cap
LNSRLENSAR	$5.84	+4.85%	+8.4%	+18.4%	10.7%	4.6	$71.7M
SKINSkinHealth Systems	$11.05	+6.76%	−40.8%	−7.8%	−3.7%	—	$72.0M	Compare
MBOTMicrobot Medical	$1.14	+4.59%	−47.9%	—	−2334.9%	—	$76.6M	Compare
LUCDLucid Diagnostics	$0.4451	+8.83%	−58.8%	+26.7%	−998.3%	—	$85.0M	Compare
SRTSSensus Healthcare	$3.25	−1.07%	−20.5%	−68.7%	−382.1%	—	$53.5M	Compare
DXRDaxor	$8.91	+2.44%	−12.1%	+2.3%	−403.2%	—	$52.0M	Compare
SNWVSANUWAVE Health	$5.73	−3.37%	−64.0%	−3.1%	−7.0%	3.4	$49.3M	Compare
MDAISpectral AI	$1.53	+2.00%	−31.1%	−30.4%	−118.5%	—	$49.2M	Compare
APYXApyx Medical	$2.59	−0.38%	−11.3%	+22.1%	−23.4%	—	$109.1M	Compare

News about LENSAR

All news →

LENSAR Stock Plunges—Alcon Scraps Merger After Prolonged Regulatory ReviewBenzinga · Mar 17, 2026▼ Negative LENSAR® Announces Termination of Merger Agreement with Alcon Research, LLCBenzinga · Mar 16, 2026▼ Negative LENSAR® Provides Update on Pending Acquisition by AlconGlobeNewswire Inc. · Feb 25, 2026Neutral

Quick answers

What does LENSAR do?: LENSAR Inc is a commercial-stage medical device company focused on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts. The company Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, simplified procedure planning, efficient design, and precision.
What is LNSR's market cap?: $71.75M, based on the Nov 4 close of $5.84.
What is LNSR's P/E ratio?: 4.6× trailing-twelve-month earnings of $15.51M.
Does LENSAR pay a dividend?: No regular cash dividend has been paid in the last year.
How much of LNSR is sold short?: 307.0K shares, 3.8% of float, as of Oct 15, 2026.
What sector is LNSR in?: Healthcare, in the Surgical Instruments industry.

About LENSAR

LENSAR Inc is a commercial-stage medical device company focused on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts. The company Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, simplified procedure planning, efficient design, and precision. Its product portfolio consists of the LENSAR Laser System with Streamline IV and IntelliAxis and its associated consumable components. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia (excluding South Korea), South Korea, and Other.

HQ: Orlando, FL150 employeesListed Sep 21, 2020lensar.com

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology